This sounds great, though the issue of false positives (and all the cost that goes along with checking on them) still remains:
Early detection of cancer significantly improves the survival rate (80%), streamlines treatment options, and ultimately reduces the cost of care. However, most early detection efforts are centered around patients who are already presenting with probable cancer symptoms. Ezra offers full-body MRI scans that are powered by AI to reduce the amount of time required to complete a scan, offering a true early-detection option for cancer and 500+ other diseases. The company’s FDA-approved AI technology in scans can be found at leading imaging centers at one of 18 locations in major cities across the US with plans to operate 50 locations in 20 cities by year’s end. While there are other providers that offer full body scans, the costs are typically prohibitive for most with pricing starting at $5000+ per scan. For individuals, Ezra offers three different scan types ranging from $1350 to $2500 with plans to offer a $500 scan in the future; family and multiyear plans are also available. The company founded in 2018 is one of the rare startups that is actually changing the world with its mission to make early cancer detection for all.
AlleyWatch caught up with Ezra Founder and CEO Emi Gal to learn more about the business, the company’s strategic plans, latest round of funding, and much, much more…
What’s your business model?
We offer multiple types of scans – our 30-minute Full Body Flash full body cancer screening scan ($1,350), our 60-minute Full Body ($1,950) that includes spine and hips analysis, and our Full Body Plus ($2,500) that includes a low-dose chest CT for lung cancer screening and coronary calcium scoring (for heart health analysis).
The Ezra business model is direct-to-consumer, cash-pay. We accept HSA/FSA dollars and have monthly installment plans available (via Affirm)